1 |
Ahn K, Johnson DS, Fitzgerald LR, Liimatta M, Arendse A, Stevenson T, Lund ET, Nugent RA, Nomanbhoy TK, Alexander JP, Cravatt BF. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry 2007. 46: 13019-13030.
DOI
ScienceOn
|
2 |
Boldrup L, Wilson SJ, Barbier AJ, Fowler CJ. A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. J Biochem Biophys Methods. 2004. 60: 171-177.
DOI
ScienceOn
|
3 |
Calignano A, La Rana G, Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol. 2001. 419: 191-198.
DOI
|
4 |
Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996. 384: 83-87.
DOI
ScienceOn
|
5 |
Cravatt BF, Lichtman AH. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol. 2003. 7: 469-475.
DOI
ScienceOn
|
6 |
Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, Sorrentini I, Di Marzo V. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology 2005. 48: 1154-1163.
DOI
ScienceOn
|
7 |
Deutsch DG, Chin SA. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol. 1993. 46: 791-796.
DOI
ScienceOn
|
8 |
Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov. 2008. 7: 438-455.
DOI
ScienceOn
|
9 |
Ganley OH, Graessle OE, Robinson HJ. Anti-inflammatory activity on compounds obtained from egg yolk, peanut oil, and soybean lecithin. J Lab Clin Med. 1958. 51: 709-714.
|
10 |
Kim DW, Kim GJ, Kim HJ, Ghil SH. Fluorescence-based assay system for endocannabinoid degradation enzyme, fatty acid amide hydrolase. J Exp Biomed Sci. 2010. 16: 279-285.
|
11 |
Kuehl Jr FA, Jacob TA, Ganley OH, Ormond RE, Meisinger MAP. The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc. 1957. 79: 5577-5578.
DOI
|
12 |
Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ. The palmitoylethanolamide family: a new class of antiinflammatory agents? Curr Med Chem. 2002. 9: 663-674.
DOI
ScienceOn
|
13 |
Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D. Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci. 2005. 62: 708-716.
DOI
ScienceOn
|
14 |
Maccarrone M, Bari M, Agro AF. A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity. Anal Biochem. 1999. 267: 314-318.
DOI
ScienceOn
|
15 |
McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005. 74: 411-432.
DOI
ScienceOn
|
16 |
Omeir RL, Chin S, Hong Y, Ahern DG, Deutsch DG. Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci. 1995. 56: 1999-2005.
DOI
ScienceOn
|
17 |
Overton HA, Babbs AJ, Doel SM, Fyfe MCT, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006. 3: 167-175.
DOI
ScienceOn
|
18 |
Rahn EJ, Thakur GA, Wood JA, Zvonok AM, Makriyannis A, Hohmann AG. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system sideeffects. Pharmacol Biochem Behav. 2011. 98: 493-502.
DOI
ScienceOn
|
19 |
Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D. An anorexic lipid mediator regulated by feeding. Nature 2001. 414: 209-212.
DOI
|
20 |
Ramarao MK, Murphy EA, Shen MW, Wang Y, Bushell KN, Huang N, Pan N, Williams C, Clark JD. A fluorescence-based assay for fatty acid amide hydrolase compatible with highthroughput screening. Anal Biochem. 2005. 343: 143-151.
DOI
ScienceOn
|
21 |
Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F, Duranti A, Tontini A, Cuzzocrea S, Tarzia G, Piomelli D. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci U S A. 2009. 106: 20966-20971.
DOI
ScienceOn
|
22 |
Sugiura T, Kishimoto S, Oka S, Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res. 2006. 45: 405-446.
DOI
ScienceOn
|
23 |
Terrazzino S, Berto F, Dalle Carbonare M, Fabris M, Guiotto A, Bernardini D, Leon A. Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB J. 2004. 18: 1580-1582.
DOI
|
24 |
Tsuboi K, Sun Y-X, Okamoto Y, Araki N, Tonai T, Ueda N. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem. 2005. 280: 11082-11092.
DOI
|
25 |
Tsuboi K, Takezaki N, Ueda N. Chem Biodivers. The N-acylethanolamine-hydrolyzing acid amidase (NAAA). 2007. 4: 1914-1925.
DOI
ScienceOn
|
26 |
Ueda N, Tsuboi K, Uyama T. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog Lipid Res. 2010. 49: 299-315.
DOI
ScienceOn
|
27 |
Wang Y, Ramirez F, Krishnamurthy G, Gilbert A, Kadakia N, Xu J, Kalgaonkar G, Ramarao MK, Edris W, Rogers KE, Jones PG. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay. J Biomol Screen. 2006. 11: 519-527.
DOI
ScienceOn
|
28 |
Wilson SJ, Lovenberg TW, Barbier AJ. A high-throughputcompatible assay for determining the activity of fatty acid amide hydrolase. Anal Biochem. 2003. 318: 270-275.
DOI
ScienceOn
|